NCT06401980
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06401980
Title Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Swiss Cancer Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries CHE

Facility Status City State Zip Country Details
Tumorzentrum Aarau TZA RECRUITING Aarau 5000 Switzerland Details
Kantonsspital Baden RECRUITING Baden 5404 Switzerland Details
Istituto Oncologico della Svizzera Italiana (IOSI) RECRUITING Bellinzona 6500 Switzerland Details
Inselspital RECRUITING Bern Switzerland Details
Kantonsspital Graubuenden RECRUITING Chur 7000 Switzerland Details
Hôpitaux Universitaires Genève HUG RECRUITING Geneva 1211 Switzerland Details
Centre Hospitalier Universitaire Vaudois CHUV RECRUITING Lausanne CH-1011 Switzerland Details
Luzerner Kantonsspital RECRUITING Lucerne 6004 Switzerland Details
Kantonsspital St. Gallen RECRUITING Sankt Gallen Switzerland Details
Kantonsspital Winterthur RECRUITING Winterthur 8401 Switzerland Details
OnkoZentrum Zürich - Standort Seefeld RECRUITING Zurich 8038 Switzerland Details
Stadtspital Triemli Zürich RECRUITING Zurich 8063 Switzerland Details
UniversitaetsSpital Zuerich RECRUITING Zurich 8091 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field